SCHEMBL9751229

SCHEMBL9751229

CCCCCCCCCCCCCCc1cccc2c1S(=O)(=O)NC2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.46
NR1H3 Q13133 1/20 0.46
GPR84 Q9NQS5 1/20 0.41
BID P55957 3/20 0.40
MCL1 Q07820 3/20 0.40
ELANE P08246 3/20 0.40
PPARA Q07869 3/20 0.40
BCL2L1 Q07817 2/20 0.40
BAK1 Q16611 2/20 0.40
KAT8 Q9H7Z6 2/20 0.40
CTSG P08311 2/20 0.40
PPARG P37231 2/20 0.40
EP300 Q09472 1/20 0.40
KAT2A Q92830 1/20 0.40
KAT2B Q92831 1/20 0.40
KAT5 Q92993 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
LIPG Q9Y5X9 1/20 0.40
KDM4E B2RXH2 1/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417559 1.00 NR1H2 (0.46) NR1H2NR1H3GPR84BIDMCL1
SCHEMBL504060 0.99 NR1H2 (0.43) NR1H2NR1H3GPR84BIDMCL1
SCHEMBL9568063 0.81 PTPRC (0.39) KDM4ECA12USP2CA1CA2
SCHEMBL529430 0.79 CA12 (0.43) KDM4ECA12USP2CA1CA2
SCHEMBL3806455 0.77 PTGER4 (0.47) PPARAKDM4ECA12USP2CA1
SCHEMBL13440433 0.75 CA12 (0.46) KDM4ECA12USP2CA1CA2
SCHEMBL2288532 0.75 KMT2A (0.38) GPR84ELANEKDM4ECA12USP2
SCHEMBL14958500 0.73 CA12 (0.39) KDM4ECA12USP2CA1CA2
SCHEMBL14799943 0.72 BID (0.46) NR1H2NR1H3BIDMCL1PPARA
SCHEMBL3807234 0.72 CA12 (0.46) MCL1KDM4ECA12USP2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0400075-A4 ENHANCEMENT OF THE THERAPEUTIC PROPERTIES OF GLYCOPROTEIN 1991-07-03 EP disclosed
EP-0400075-A1 ENHANCEMENT OF THE THERAPEUTIC PROPERTIES OF GLYCOPROTEIN GENZYME CORPORATION (US) 1990-12-05 EP disclosed
WO-1989007641-A1 ENHANCEMENT OF THE THERAPEUTIC PROPERTIES OF GLYCOPROTEIN GENZYME CORPORATION (US) 1989-08-24 WO disclosed